share_log

Canaccord Genuity Maintains Buy on Privia Health Gr, Lowers Price Target to $37

Canaccord Genuity Maintains Buy on Privia Health Gr, Lowers Price Target to $37

Canaccord Genuity 維持對Privia Health Gr的買入,將目標股價下調至37美元
Benzinga ·  03/19 18:46

Canaccord Genuity analyst Richard Close maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target from $41 to $37.

Canaccord Genuity分析師理查德·克洛斯維持Privia Health Gr(納斯達克股票代碼:PRVA)的買入並將目標股價從41美元下調至37美元。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論